Fouad Namouni

CIK: 0001815851

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

VOR

Vor Biopharma Inc.

Director

BPMC

Blueprint Medicines Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

VOR
Vor Biopharma Inc.
Jun 11, 2026
Award(A)
Stock Option (right to buy)
Direct
56.5K shares-
BPMC
Blueprint Medicines Corp
Jul 17, 2025
Disposition(D)
Direct
83.3K shares-
BPMC
Blueprint Medicines Corp
Jul 17, 2025
Tender Offer(U)
Direct
32K shares-
BPMC
Blueprint Medicines Corp
Jul 17, 2025
Award(A)
Direct
39.5K shares-
VOR
Vor Biopharma Inc.
May 22, 2025
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-
BPMC
Blueprint Medicines Corp
Mar 5, 2025
Sale(S)
Direct
6.5K shares at avg. $88.80$576K
BPMC
Blueprint Medicines Corp
Mar 1, 2025
Award(A)
Direct
13.2K shares-
BPMC
Blueprint Medicines Corp
Oct 3, 2024
Sale(S)
Direct
3.6K shares at avg. $89.32$324K

		Type	Shares	Price		Ownership
Jun 11, 2026	VOR Vor Biopharma Inc.	Award(A) Stock Option (right to buy)	56,549	-	-	Direct
Jul 17, 2025	BPMC Blueprint Medicines Corp	Disposition(D)	83,281	-	-	Direct
Jul 17, 2025	BPMC Blueprint Medicines Corp	Tender Offer(U)	31,956	-	-	Direct
Jul 17, 2025	BPMC Blueprint Medicines Corp	Award(A)	39,456	-	-	Direct
May 22, 2025	VOR Vor Biopharma Inc.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct
Mar 5, 2025	BPMC Blueprint Medicines Corp	Sale(S)	6,489	$88.80	$576,223	Direct
Mar 1, 2025	BPMC Blueprint Medicines Corp	Award(A)	13,200	-	-	Direct
Oct 3, 2024	BPMC Blueprint Medicines Corp	Sale(S)	3,633	$89.32	$324,500	Direct

1-8 of 8 transactions

About Namouni Fouad

Namouni Fouad (SEC CIK 0001815851) files insider reports with the SEC as Director of Vor Biopharma Inc. (VOR) and PRESIDENT, R & D of Blueprint Medicines Corp (BPMC).

Signal8 holds 6 ownership filings by Namouni Fouad, all Form 4s, filed between Oct 4, 2024 and Jun 12, 2026. Those filings report 8 transactions, from Oct 3, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Namouni Fouad's filings is in BOSTON, MA.

Recent filings by Namouni Fouad

Jun 11, 2026: Grant or award of VOR derivative securities (Form 4, code A).
Jul 17, 2025: Disposition to issuer transaction of BPMC shares (Form 4, code D).
Jul 17, 2025: Tender of shares transaction of BPMC shares (Form 4, code U).
Jul 17, 2025: Grant or award of BPMC shares (Form 4, code A).
May 22, 2025: Grant or award of VOR derivative securities (Form 4, code A).

Other insiders filing for Vor Biopharma Inc. (VOR)

RA CAPITAL MANAGEMENT, L.P., 10% Owner
ZACCARDELLI DAVID, Director
Detheux Michel, Director
Joustra Wouter, Director
Kalir Erez, Director
Cumbo Alexander, Director

How to read Form 4 transaction codes